Osteoporosis in children with cancer

Pediatric Blood and Cancer

Volumn 50, Issue 2 SUPPL., 2008, Pages 474-478

  Van Der Sluis, Inge M ^a   Van Den Heuvel Eibrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Bone mineral density; Childhood cancer; Fractures; Osteoporosis; Risk factors; Treatment

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DEXAMETHASONE; GLUCOCORTICOID; IFOSFAMIDE; PAMIDRONIC ACID; PREDNISOLONE; VINCRISTINE; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE MINERALIZATION; BONE PAIN; BONE TURNOVER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; FANCONI RENOTUBULAR SYNDROME; FOLLOW UP; FRACTURE; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; HORMONE RELEASE; HUMAN; HYPOCALCEMIA; JUVENILE RHEUMATOID ARTHRITIS; NEUROPATHY; NONHODGKIN LYMPHOMA; OSTEOBLAST; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SOLID TUMOR; VITAMIN SUPPLEMENTATION;

BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; EXERCISE; HUMANS; NEOPLASMS; OSTEOPOROSIS; RISK FACTORS;

EID: 37549054691     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21407     Document Type: Review

References (33)

1. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010-2018.
2. Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996;11:1774-1783.
3. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-210.
4. Brennan BM, Rahim A, Adams JA, et al. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer 1999;79:1859-1863.
5. Brennan BM, Mughal Z, Roberts SA, et al. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. J Clin Endocrinol Metab 2005;90:689-694.
6. Jarfelt M, Fors H, Lannering B, et al. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 2006;154:303-309.
7. Marinovic D, Dorgeret S, Lescoeur B, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: A 1-year prospective study. Pediatrics 2005;116:e102-e108.
8. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000;35:415-420.
9. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, et al. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006;46:88-93.
10. Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998;20:234-240.
11. Odame I, Duckworth J, Talsma D, et al. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer 2006;46:357-362.
12. Hopewell JW. Radiation-therapy effects on bone density. Med Pediatr Oncol 2003;41:208-211.
13. Holzer G, Krepler P, Koschat MA, et al. Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg Br 2003;85:231-237.
14. Ruza E, Sierrasesumaga L, Azcona C, et al. Bone mineral density and bone metabolism in children treated for bone sarcomas. Pediatr Res 2006;59:866-871.
15. Othman F, Guo CY, Webber C, et al. Osteopenia in survivors of Wilms tumor. Int J Oncol 2002;20:827-833.
16. Hesseling PB, Hough SF, Nel ED, et al. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer 1998;11:44-47.
17. Arikoski P, Komulainen J, Riikonen P, et al. Impaired development of bone mineral density during chemotherapy: A prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res 1999;14:2002-2009.
18. van der Sluis IM, de Muinck Keizer-Schrama SM. Osteoporosis in childhood: Bonedensity of children in health and disease. J Pediatr Endocrinol Metab 2001;14:817-832.
19. Frost HM, Schonau E. The "muscle-bone unit" in children and adolescents: A 2000 overview. J Pediatr Endocrinol Metab 2000; 13:571-590.
20. van Beek RD, van den Heuvel-Eibrink MM, de Jonge R, et al. Single nucleotide polymorpisms of the MTHFR(C677T), MTRR(A66G) and vitamin D receptor (CDx/GATA) genes are important determinants of osteoporosis in pediatric ALL patients. Haematologica 2006;91:359 (abstr).
21. Huizenga NA, Koper JW, De Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144-151.
22. Goulding A, Jones IE, Taylor RW, et al. More broken bones: A 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000;15:2011-2018.
23. Smith CB, Smith DA. Relations between age, mineral density and mechanical properties of human femoral compacta. Acta Orthop Scand 1976;47:496-502.
24. Schnitzler CM. Bone quality: A determinant for certain risk factors for bone fragility. Calcif Tissue Int 1993;53:S27-S31.
25. Winzenberg TM, Shaw K, Fryer I, et al. Calcium supplementation for improving bone mineral density in children. Cochrane Database Syst Rev 2006; CD005119.
26. Pettersson U, Nordstrom P, Alfredson H, et al. Effect of high impact activity on bone mass and size in adolescent females: A comparative study between two different types of sports. Calcif Tissue Int 2000;67:207-214.
27. Fuchs RK, Bauer JJ, Snow CM. Jumping improves hip and lumbar spine bone mass in prepubescent children: A randomised controlled trial. J Bone Miner Res 2001;16:148-156.
28. Thornton J, Ashcroft DM, Mughal Z, et al. Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis. Arch Dis Child 2006;91:753-761.
29. Acott PD, Wong JA, Lang BA, et al. Pamidronate treatment of pediatric fracture patients on chronic steroid therapy. Pediatr Nephrol 2005;20:368-373.
30. Shaw NJ, Bishop NJ. Bisphosphonate treatment of bone disease. Arch Dis Child 2005;90:494-499.
31. Goldbloom EB, Cummings EA, Yhap M. Osteoporosis at presentation of childhood ALL: Management with pamidronate. Pediatr Hematol Oncol 2005;22:543-550.
32. Barr RD, Guo CY, Wiernikowski J, et al. Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with Pamidronate. Med Pediatr Oncol 2002;39:44-46.
33. Wiernikowski JT, Barr RD, Webber C, et al. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: Results of a pilot study. J Oncol Pharm Pract 2005;11:51-56.